Objective The objective of this study was to identify and summarize the efficacy and safety of
systemic glucocorticoids (GCs) and local injections of GC in SpA. Methods PubMed …

Objectives The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) has been
widely utilized to evaluate disease activity in patients with ankylosing spondylitis (AS) by an …

Background: Patients with ankylosing spondylitis (AS) suffer from impaired physical activity
and are prone to motor vehicle accidents (MVA), but definite instruction regarding the …

The burden of axial spondyloarthropathy (axSpA) in the Asia‐Pacific region is substantial.
The management of axSpA has been revolutionized with the advent of biological therapy …

To investigate the impact of an electronic medical record management system (EMRMS) on
disease activity and the frequency of outpatient visits among patients with ankylosing …

Background: Potential risk factors for major adverse cardiovascular events (MACE) in
patients with ankylosing spondylitis (AS) requiring medical therapy should be investigated …

Objective The number of therapies for axial spondyloarthritis (axSpA) is increasing. Thus, it
has become more challenging for patients and physicians to navigate the risk‐benefit …

Purpose Current treatment options for head and neck squamous cell carcinoma (HNSCC)
are limited, especially for cases with cancer stem cell-induced chemoresistance and …

Introduction Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease in
which T-cell immune responses play important roles. AS has been characterized by altered …

Study Design. Prospective case-control study. Objective. To explore the role of Bruton's
tyrosine kinase (BTK) in ankylosing spondylitis (AS). Summary of Background Data. AS …